报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 0.61% | -69.19% | 10.91% | 98/129 | 4.79% | 迈瑞医疗 | 28.68% | 行业排名> |
2024-06-30 | 0.55% | -65.84% | 816.67% | 90/129 | 3.05% | 迈瑞医疗 | 20.2% | 行业排名> |
2024-03-31 | 0.06% | -57.14% | -84.62% | 104/129 | 1.68% | 迈瑞医疗 | 9.12% | 行业排名> |
2023-12-31 | 0.39% | -89.4% | -80.3% | 98/129 | 5.06% | 迈瑞医疗 | 33.21% | 行业排名> |
2023-09-30 | 1.98% | -50.75% | 22.98% | 95/129 | 5.79% | 迈瑞医疗 | 28.34% | 行业排名> |
2023-06-30 | 1.61% | -21.46% | 1050% | 87/129 | 3.8% | 迈瑞医疗 | 18.36% | 行业排名> |
2023-03-31 | 0.14% | 153.85% | -96.2% | 105/129 | 2.29% | 安杰思 | 8.56% | 行业排名> |
2022-12-31 | 3.68% | -16.36% | -8.46% | 96/129 | 13.44% | 九安医疗 | 146.56% | 行业排名> |
2022-09-30 | 4.02% | -28.98% | 96.1% | 89/129 | 12.77% | 九安医疗 | 140.94% | 行业排名> |
2022-06-30 | 2.05% | -41.26% | 888.46% | 95/129 | 9.3% | 九安医疗 | 142.25% | 行业排名> |
2022-03-31 | -0.26% | -110.57% | -105.91% | 101/129 | 6.26% | 九安医疗 | 142.71% | 行业排名> |
2021-12-31 | 4.4% | -19.41% | -22.26% | 108/129 | 17.49% | 热景生物 | 121.78% | 行业排名> |
2021-09-30 | 5.66% | 2% | 62.18% | 88/129 | 15.94% | 热景生物 | 99.69% | 行业排名> |
2021-06-30 | 3.49% | 89.67% | 41.87% | 97/129 | 11.54% | 热景生物 | 99.09% | 行业排名> |
2021-03-31 | 2.46% | 2% | -54.95% | 63/129 | 6.23% | 热景生物 | 57.63% | 行业排名> |
2020-12-31 | 5.46% | -1.44% | 196.74% | 103/129 | 25.82% | 中红医疗 | 168% | 行业排名> |
2020-06-30 | 1.84% | 2% | -66.79% | 95/129 | 15.16% | 圣湘生物 | 112.46% | 行业排名> |
2019-12-31 | 5.54% | 134.75% | 134.75% | 95/129 | 14.38% | 博拓生物 | 108.13% | 行业排名> |
2018-12-31 | 2.36% | -49.25% | -49.25% | 93/129 | 12.98% | 圣湘生物 | 29.33% | 行业排名> |
2017-12-31 | 4.65% | 2% | 2% | 83/129 | 13.82% | 健尔康 | 84.09% | 行业排名> |